Novartis is looking to digital storytelling as a way to help cancer patients and their families. Last week, the pharma company announced that it would be launching the Galaxies of Hope app, which lets patients, providers, and caregivers explore the challenges of coping with neuroendocrine tumor (NET) cancer through a multimodal approach.
Multiplayer surgeries. Virtual reality surgical training app maker Osso VR today launched a feature that allows multiple surgeons to train and interact within a single VR space. The new functionality can bring team members together for training regardless of physical location, according to a statement, and comes with the other benefits of collaborative, team-based training over solo instruction.
Healthcare AI company Viz.ai announced today that it has raised $21 million in Series A funding. The investment was led by Kleiner Perkins, with additional participation from GV (formerly Google Ventures).
Israel is continuing to carve out its space as a digital health hub in the Middle East. Today the Israeli government announced a $33 million grant aimed at furthering the country's foothold in digital health, specifically in biotech and medicine, according to Reuters.
Centivo, a self-funded health plan supported by a digital platform, has brought in $34 million in a Series A funding round led by Bain Capital Ventures, the company announced today. Other backers include F-Prime Capital Partners, Maverick Ventures, Bessemer Venture Partners, Ingleside Investors, Rand Capital, Grand Central Tech Ventures, Oxeon Investments, and individual investors including Jim Foreman, Ken Goulet, and Kevin Hill.
• Provider-focused telemedicine vendor SnapMD’s Virtual Care Management system will be used to teach students at the University of San Diego (USD) Hahn School of Nursing and Health Science about telehealth. In a class called “Telehealth and Emerging Technology”, students will learn the ins and outs of virtual visits.
VitalConnect and physIQ are teaming up with the Haga Teaching Hospital in the Netherlands to conduct a study on how wearable biosensors and artificial intelligence can augment care for cancer patients undergoing treatment. Specifically, the study — which is funded by Johnson & Johnson subsidiary Janssen Pharmaceuticals — is looking to see how the technology can detect adverse events in cancer treatment early on.
CyberMDX, a connected medical device and clinical network security firm, announced today that it has closed $10 million in Series A funding. The financing round was led by Pitango Venture Capital, with additional backing from OurCrowd Qure.
The company’s MDefend software product is deployed to a provider’s network, CyberMDX CEO Amir Magner told MobiHealthNews. The tool is non-intrusive, and doesn’t apply any software within the protected devices themselves.
Personalized health information company K Health has launched a free primary care app. Called K, the app’s AI references a history of diagnoses and treatments to deliver users an insight about how their condition would likely be treated, and can also connect users to a network of primary care providers.